ACCL vs NCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

ACCL

42.9
AI Score
VS
NCI Wins

NCI

43.6
AI Score

Investment Advisor Scores

ACCL

43score
Recommendation
HOLD

NCI

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACCL NCI Winner
Revenue 5.14M 17.63M NCI
Net Income 286,445 42,615 ACCL
Gross Margin 42.7% 36.9% ACCL
Net Margin 5.6% 0.2% ACCL
Operating Income 231,237 231,904 NCI
ROE 4.8% 0.6% ACCL
ROA 3.7% 0.3% ACCL
Total Assets 7.82M 14.86M NCI
Cash 5.63M 299,730 ACCL
Current Ratio 4.21 2.61 ACCL
Free Cash Flow 546,479 2.23M NCI

Relative Price Performance (Last 90 Days)

ACCL 1M: +13.4% · 3M: +36.6% NCI 1M: -94.6% · 3M: -93.4%

Current Technical Phase

ACCL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.7% over 20 days), RSI 57

RSI (14): 57.1 · Price: $2.87

NCI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -34.7%), weak momentum, RSI 18

RSI (14): 17.6 · Price: $0.79

Fundamentals Snapshot

Metric ACCL NCI
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E 131.5 9.0
Revenue (TTM) — —
Revenue Growth 0.0% -0.5%
Gross Margin 0.4% 0.4%
Operating Margin 0.0% 0.0%
EPS 0.02 0.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NCI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.